Pharma Journalist -

Noxopharm announces that it has entered into a research agreement with the University of Hong Kong to conduct research into the use of the drug idronoxil (NOX66 active ingredient) to…
Read More...

Medical researchers and IBM are asking for the public's help in identifying prospective treatments for childhood cancers. Scientists are searching for chemical drug candidates that…
Read More...

Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen…
Read More...

Astellas Pharma Inc. and Ironwood Pharmaceuticals, Inc. announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic…
Read More...

Endo International plc announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug…
Read More...

Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris'…
Read More...

Mallinckrodt plc announced that it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K.,…
Read More...

Sanofi announced the appointment of Kathleen Tregoning as member of Executive committee, effective February 27, 2017. Ms. Tregoning will lead Sanofi’s External Affairs organization…
Read More...

uniQure announced that AMT-060,  its proprietary, investigational gene therapy in patients with severe hemophilia B, has received Breakthrough Therapy designation by the U.S. Food and…
Read More...

Mallinckrodt plc, a leading specialty pharmaceutical company, announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690…
Read More...